Close this search box.

We are creating some awesome events for you. Kindly bear with us.

The Philippines to Deploy New Research Facility for Improving Medical Diagnosis

Although health outcomes in low- and middle-income countries (LMICs) have improved over the last several decades, a new reality is on the horizon. Changing health needs, rising public expectations, and bold new health goals are pushing health systems to produce better health outcomes and greater social value. Notwithstanding, continuing the current path will not suffice to meet these demands. High-quality healthcare systems are required to optimise healthcare delivery in each context by continuously delivering care that improves or maintains health, being valued and trusted by all people, and adapt to the changing population needs.

Health research, like privacy, is extremely valuable to society. It can provide valuable information about disease trends and risk factors, clinical outcome or public health interventions, functional abilities, care patterns, and health care costs and utilisation. The various research approaches provide complementary insights. Clinical trials can provide important information about the efficacy and side effects of medical interventions by controlling the variables that could influence the study’s results, but feedback from real-world clinical experience is also essential for comparing and enhancing the use of drugs, vaccines, medical devices, and diagnostics

According to the Executive Director of the Philippine Council for Health Research and Development (PCHRD), approximately PHP175 million has been allocated for the establishment of a research facility that may be used for improved disease diagnosis or management, which is set to open this September. The Protein, Proteomics, and Metabolomics Facility (PPMF) are located on the second floor of the Philippine Genome Centre main building within the University of the Philippines’ National Science Complex.

“The PPMF will provide Filipino researchers with the capability to investigate proteomes and metabolomes. These are the collections of proteins and metabolites within an organism that provide their actual characteristics. While the genomes provide a glimpse of the potential traits, the proteomes and metabolomes show the actual picture of the state of an organism or target sample,” he noted.

He cited that proteomics analysis may be used to identify “biomarkers” of a disease like cancer. “Relating these biomarkers to the state of the disease may reveal important proteins that may be used for better diagnosis or management of the disease. Detecting these biomarkers in successive patients may then be used for better ‘personalised treatment’ of these patients,” he then explained.

The facility would allow researchers to conduct more direct analyses on the causes of specific diseases or special traits that may be found in the Philippines’ unique resources, he added. According to him, the Department of Science and Technology has set aside PHP175 million for this purpose. He explained that the new facility will increase the country’s ability to use multi-omics technology.

The main objective of multi-omics, also known as integrated omics, pan-omics, and trans-omics, is to combine two or more omics data sets to aid in data analysis, visualisation, and interpretation in order to determine the mechanism of a biological process. Multi-omics efforts have taken centre stage in biomedical research, resulting in the discovery of new biological events and processes.

“Combined with (PGC’s) DNA Sequencing Core Facility which studies the DNA (Deoxyribonucleic acid) and RNA (Ribonucleic acid), the PPMF expands the available infrastructure to allow the analysis of the protein and metabolite products in target organisms. These capabilities are (intended for all) Filipino researchers,” he remarked.

The executive asserted that the PGC’s mission is to accommodate the use of available resources for the empowerment of other researchers, not just to perform world-class research within the institution. Advances in health information technology are enabling a transformation in health research that could enable previously unfeasible studies, leading to new insights about health and disease.


Qlik’s vision is a data-literate world, where everyone can use data and analytics to improve decision-making and solve their most challenging problems. A private company, Qlik offers real-time data integration and analytics solutions, powered by Qlik Cloud, to close the gaps between data, insights and action. By transforming data into Active Intelligence, businesses can drive better decisions, improve revenue and profitability, and optimize customer relationships. Qlik serves more than 38,000 active customers in over 100 countries.


CTC Global Singapore, a premier end-to-end IT solutions provider, is a fully owned subsidiary of ITOCHU Techno-Solutions Corporation (CTC) and ITOCHU Corporation.

Since 1972, CTC has established itself as one of the country’s top IT solutions providers. With 50 years of experience, headed by an experienced management team and staffed by over 200 qualified IT professionals, we support organizations with integrated IT solutions expertise in Autonomous IT, Cyber Security, Digital Transformation, Enterprise Cloud Infrastructure, Workplace Modernization and Professional Services.

Well-known for our strengths in system integration and consultation, CTC Global proves to be the preferred IT outsourcing destination for organizations all over Singapore today.


Planview has one mission: to build the future of connected work. Our solutions enable organizations to connect the business from ideas to impact, empowering companies to accelerate the achievement of what matters most. Planview’s full spectrum of Portfolio Management and Work Management solutions creates an organizational focus on the strategic outcomes that matter and empowers teams to deliver their best work, no matter how they work. The comprehensive Planview platform and enterprise success model enables customers to deliver innovative, competitive products, services, and customer experiences. Headquartered in Austin, Texas, with locations around the world, Planview has more than 1,300 employees supporting 4,500 customers and 2.6 million users worldwide. For more information, visit


SIRIM is a premier industrial research and technology organisation in Malaysia, wholly-owned by the Minister​ of Finance Incorporated. With over forty years of experience and expertise, SIRIM is mandated as the machinery for research and technology development, and the national champion of quality. SIRIM has always played a major role in the development of the country’s private sector. By tapping into our expertise and knowledge base, we focus on developing new technologies and improvements in the manufacturing, technology and services sectors. We nurture Small Medium Enterprises (SME) growth with solutions for technology penetration and upgrading, making it an ideal technology partner for SMEs.


HashiCorp provides infrastructure automation software for multi-cloud environments, enabling enterprises to unlock a common cloud operating model to provision, secure, connect, and run any application on any infrastructure. HashiCorp tools allow organizations to deliver applications faster by helping enterprises transition from manual processes and ITIL practices to self-service automation and DevOps practices. 


IBM is a leading global hybrid cloud and AI, and business services provider. We help clients in more than 175 countries capitalize on insights from their data, streamline business processes, reduce costs and gain the competitive edge in their industries. Nearly 3,000 government and corporate entities in critical infrastructure areas such as financial services, telecommunications and healthcare rely on IBM’s hybrid cloud platform and Red Hat OpenShift to affect their digital transformations quickly, efficiently and securely. IBM’s breakthrough innovations in AI, quantum computing, industry-specific cloud solutions and business services deliver open and flexible options to our clients. All of this is backed by IBM’s legendary commitment to trust, transparency, responsibility, inclusivity and service.